{"changeSha256":"f4b16c10b555a4af0583cba623630609bb0492518f21423a2a101b3a9adb58c4","changedAt":"2026-11-14","changedFields":[{"after":"FDA-approved as Forteo and other teriparatide products","before":"U.S. label record","field":"Status"},{"after":"A parathyroid hormone analogue first approved by FDA as Forteo in 2002 for osteoporosis at high risk of fracture.","before":"A parathyroid hormone analogue. This profile cites a U.S. label record.","field":"Profile summary"},{"after":"A large randomized, placebo-controlled trial described in the label found fewer new spine fractures than placebo. The label states that teriparatide caused osteosarcoma in rats; an increased risk has not been observed in human observational studies.","before":"The cited DailyMed label identifies Teriparatide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.","field":"Evidence note"},{"after":"Forteo","before":"None recorded","field":"Related names"},{"after":"dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb","before":"dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9]; U.S. Food and Drug Administration [sources: fda-drugs-nda021318-2002-11-26-2f4c2df07e0a]","before":"U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9]","field":"Named organizations"},{"after":"name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9","before":"name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/teriparatide/versions/3/","version":3},"id":"profile:teriparatide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-status-changed","notice":"We added a plain-language reader guide with cited answers, re-checked the generic teriparatide label, and added Drugs@FDA approval records for teriparatide products.","peptideSlugs":["teriparatide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/teriparatide/v2.json","sha256":"6dd9d8b3534f7d9226d993270a00e1731690b5d6ee6805578dddaba4f3f2f55b"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/teriparatide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"Teriparatide injection, solution · SPL version 9 · published 2026-06-30","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=d77d40db-7f38-88eb-fd5d-4282f0642028&version=9","verifiedAt":"2026-07-22"},{"id":"fda-drugs-nda021318-2002-11-26-2f4c2df07e0a","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA021318 · original submission status AP · 2002-11-26 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA021318%22&limit=1","verifiedAt":"2026-08-14"}],"subject":{"slug":"teriparatide","type":"profile"}}
